JPRN-UMIN000008811已完成2 期
Bevacizumab Combined With Cisplatin Plus Pemetrexed as Front-line Chemotherapy for Asymptomatic Brain Metastases in Non-squamous Non-small Cell Lung Cancer. - Bevacizumab With Cisplatin Plus Pemetrexed for Asymptomatic Brain Metastases in Non-Sq NSCLC
Hanshin Oncology Group0 个研究点目标入组 35 人开始时间: 2013年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of severe drug allergy 3)History of active infection or other serious disease condition (GI bleeding,etc.) 4)History of poorly controlled pleural effusion,pericardial effusion and ascites 5)History of severe heart disease(uncontrollable arrythmia,uncontrollable angina pectoris,herat failure,etc.) 6)Uncontrollable hypertension 7)Uncontrollable diabetes mellitus 8)Hystory of active double cancer 9)Invasion to main blood vessels 10)History of active psychological disease 11)Severe hemoptysis or blood sputum 12)History of gastrointestinal perforation 13)Symptomatic or more than 2 cm diameter brain metastases 14)Uncured bone fracture (excluding compression fracture due to osteoporosis) 15)Planned surgery 16)Obvious cavity on pulmonary lesions. 17)Bleeding tendency 18)Uncontrolled thromboembolizm 19)Pregnancy 20)Participation in the trial is judged to be inappropriate by the attending doctor
研究者
相似试验
已完成
2 期
Phase II study of cisplatin, pemetrexed plus bevacizumab for EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell lung cancer)EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell carcinoma)JPRN-UMIN000003855Departmnent of Thoracic Oncology Kanagawa Cancer Center25
已完成
2 期
A phase II study of Cisplatin+Pemetrexed +Bevacizumab for gefitinib refractory NSCLC patients with mutated EGFRon-small cell lung cancer(Non squamous)JPRN-UMIN000012215iigata Lung Cancer Treatment Group28
已完成
2 期
Weekly Paclitaxel in Combination with Bevacizumab in Patients with Non-Squamous Non-Small Cell Lung Cancer Who Have Failed Previous Treatments-Phase II studyPatients with non-squamous non-small cell lung cancer who have failed previous treatmentsJPRN-UMIN000005608Division of Medical Oncology and Molecular Respirology Department of Multidisciplinary Internal Medicine Faculty of Medicine, Tottori University31
已完成
2 期
Weekly Paclitaxel in Combination with Bevacizumab in Patients with Non-Squamous Non-Small Cell Lung Cancer Previously Untreated -A Phase II studyPatients with non-squamous non-small cell lung cancer previously untreatedJPRN-UMIN000014345Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University36
招募中
不适用
A cohort study of Pemetrexed plus Cisplatin Plus Bevacizumab in patients with previously untreated stage III/IV or non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancerJPRN-UMIN000009081ara Medical University Hospital30